Peptides for Sleep — The Complete Guide

Delta Wave Promotion · Pineal Regulation · Melatonin Restoration

Two peptides act directly on the machinery that determines sleep depth and structure. DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide originally isolated from rabbit thalamic venous blood during electrically induced sleep — named for its ability to directly promote delta wave oscillations, the slow, high-amplitude brain waves that define N3 slow-wave sleep. Its mechanism involves modulation of thalamic and hypothalamic sleep-generating circuits, normalization of cortisol excess that suppresses deep sleep, and direct promotion of the delta wave activity that distinguishes restorative sleep from light, fragmented cycling. Epithalon addresses the pineal gland — restoring melatonin production and circadian entrainment without the receptor downregulation of exogenous melatonin supplementation. Its telomerase activation also reduces the cellular aging in pineal tissue itself.

GABAergic Modulation · Cortisol Suppression · Serotonin Stabilization

Cortisol is the primary neurobiological antagonist of slow-wave sleep. The HPA axis — when chronically activated by stress — maintains elevated evening cortisol that delays sleep onset, suppresses deep stages, and promotes fragmented cycling. Selank is a synthetic analog of tuftsin with established anxiolytic activity mediated through GABAergic modulation and serotonin system stabilization. Its GABAergic mechanism reduces the central nervous system hyperarousal that keeps cortisol elevated into the evening sleep window, without the tolerance development, dependency, and morning cognitive impairment that characterize benzodiazepine and Z-drug agents. At VitalRx, Selank is available in the combined Semax/Selank nasal spray — evening administration allows Selank's calming effect to support cortisol normalization and sleep onset.

Growth Hormone · Pulsatile Secretion · Bidirectional GH-Sleep Coupling

Growth hormone and slow-wave sleep are bidirectionally coupled: deep sleep is the primary stimulus for the pituitary's overnight GH pulse, and adequate GH is required for sleep to be architecturally deep. This coupling creates a reinforcing cycle in either direction — declining GH produces shallower sleep, which produces less GH stimulus, which further shallows sleep. GH secretagogues interrupt this decline by stimulating the pituitary to release GH through its natural pulsatile mechanism. CJC-1295/Ipamorelin provides the strongest overnight GH pulse; Sermorelin offers a more conservative approach; Ibutamoren (MK-677) is the only oral GH secretagogue with published human study data specifically showing slow-wave sleep extension.

Parasympathetic Shift · SNS Reduction · Circadian Entrainment

Oxytocin has a direct and under-appreciated role in sleep biology. Central oxytocin receptor activation in the hypothalamus promotes sleep onset by reducing sympathetic nervous system arousal, reducing cortisol and stress reactivity in the pre-sleep window, and activating the parasympathetic shift required for the transition from wakefulness to sleep. Oxytocin also modulates circadian entrainment through its interaction with the suprachiasmatic nucleus. At VitalRx, oxytocin is available as a nasal spray (100 IU/mL, 5mL) for rapid mucosal absorption and CNS access, and as troches (50IU or 120IU) for sublingual delivery with a slower absorption profile suited to sustained pre-sleep administration.

Core Sleep Architecture Compound

• Directly promotes delta wave (N3) slow-wave sleep — the deepest, most restorative stage
• Normalizes disturbed sleep architecture without morning sedation carry-over
• Reduces excess cortisol that suppresses deep sleep stages
• Improves sleep onset in patients with thalamic and hypothalamic sleep-circuit dysregulation
• No dependency or tolerance development — works within endogenous sleep-generating circuits
• Addresses fragmented, shallow cycling sleep patterns that leave patients unrefreshed despite hours in bed

• Directly restores pineal gland regulatory function — the source of endogenous melatonin
• Normalizes melatonin production without the receptor downregulation of exogenous melatonin supplements
• Improves circadian entrainment signal — makes the sleep-wake transition cleaner and more reliable
• Telomerase activation reduces cellular aging in pineal tissue — addresses upstream cause of melatonin decline
• Produces more consistent, stable sleep-wake cycling rather than temporary melatonin level elevation
• Additional longevity and neuroprotective benefits alongside sleep architecture improvement

• Selank: GABAergic modulation reduces evening hyperarousal and cortisol that blocks deep sleep
• Serotonin system stabilization — addresses the anxiety and rumination pattern that delays sleep onset
• No tolerance, dependency, or morning cognitive impairment — unlike benzodiazepine and Z-drug GABAergic agents
• Intranasal delivery — rapid CNS absorption for pre-sleep evening administration
• Semax component provides daytime neurotrophic and attentional benefits when used morning-and-evening
• Addresses the root neurochemical state of stress-driven insomnia rather than overriding wakefulness

• Strongest GH pulse stimulation in the VitalRx catalog — dual GHRH analog and ghrelin receptor activation
• Deepens slow-wave sleep stages — restoring N3 time that declines with age-related GH reduction
• Stimulates 70–80% of daily GH output that occurs within slow-wave sleep
• GH-driven IGF-1 drives the neurogenesis, tissue repair, and metabolic restoration that make sleep restorative
• Patients typically notice improved depth of sleep and more refreshed waking within 2–4 weeks
• No exogenous GH — preserves pituitary feedback and natural pulsatility

• GHRH analog — stimulates pituitary GH release through natural growth hormone-releasing hormone pathway
• More conservative GH stimulation than CJC-1295/Ipamorelin — appropriate starting point for GH-naive patients
• Deepens slow-wave sleep and improves sleep quality through GH-dependent architecture mechanisms
• Shorter active half-life than CJC-1295 — more physiologically conservative pulse profile
• Well-established safety and tolerability profile across published literature
• Cost-effective entry point for GH secretagogue sleep support

• Only oral GH secretagogue in the VitalRx catalog — ghrelin receptor agonism without injection
• Published human study data specifically showing slow-wave sleep extension with Ibutamoren use
• Increases GH pulsatility and IGF-1 — improving both the quantity and quality of overnight repair
• Convenient nightly oral dosing — appropriate for patients who prefer to minimize injections
• 12.5mg starting dose for tolerability; 25mg for full sleep and GH effect
• May be combined with DSIP injectable for oral-plus-injectable sleep stack

• Activates central oxytocin receptors in the hypothalamus — drives the parasympathetic shift needed for sleep onset
• Reduces sympathetic nervous system hyperarousal and stress reactivity at bedtime
• Modulates suprachiasmatic nucleus circadian signaling — supports clean sleep-wake entrainment
• Rapid intranasal CNS delivery — suitable for administration 20–30 minutes before bed
• Reduces cortisol and anxiety in the pre-sleep window through hypothalamic oxytocin receptor activation
• Most accessible sleep compound in the VitalRx catalog — affordable and non-injectable

• Sublingual delivery — slower, more sustained absorption profile than nasal spray
• Appropriate when sustained oxytocin exposure through the early sleep window is preferred
• 50IU for lighter dosing; 120IU for fuller sustained oxytocin effect through sleep onset
• No injection required — fully non-invasive delivery format
• Complements injectable sleep compounds for patients who want mixed-route protocols
• Same central mechanism as nasal spray — parasympathetic shift, SNS reduction, circadian support

Patients who sleep 7–8 hours but wake feeling unrestored, patients whose sleep tracking shows minimal N3 time, or patients who feel they never experience truly deep sleep.

Patients who lie in bed awake, who have elevated pre-sleep arousal, racing thoughts, or hypervigilance that delays sleep onset by 30+ minutes.

The most common sleep pattern in adults over 45: sleep that has gradually worsened over years, becoming lighter, more fragmented, less restorative.

Patients whose sleep problems are clearly connected to stress — those who sleep well on holiday but poorly during work periods, those with HPA axis dysregulation or anxiety-driven insomnia.

Days 1–14

Acute Onset and Architecture Effects

Oxytocin nasal spray and Selank produce their parasympathetic and anxiolytic effects from the first use — many patients notice improved sleep onset and reduced pre-sleep arousal within the first 1–2 weeks. DSIP's delta wave promotion is typically apparent within the first 1–2 weeks — patients report sleeping more deeply, waking less frequently, and feeling more genuinely rested. GH secretagogue sleep quality improvements often emerge within the first 2 weeks as the first GH pulses occur.

Weeks 2–6

GH Pulse Restoration and Architecture Normalization

CJC-1295/Ipamorelin and Sermorelin GH pulses build in consistency through this period, with patients reporting progressively more restorative sleep, improved morning energy, and faster physical recovery. Ibutamoren's documented slow-wave sleep extension effects typically consolidate through weeks 3–6. DSIP-supported patients often notice that sleep quality has normalized sufficiently that their wearable data begins reflecting more N3 time.

Months 2–4 and Beyond

Circadian Restoration and Protocol Compounding

Epithalon's pineal normalization effects develop over months as the restored melatonin production signal progressively improves circadian entrainment — patients describe a qualitative shift in sleep reliability and consistency rather than just depth. The most comprehensive protocols — DSIP plus GH secretagogue plus Epithalon — tend to produce compounding improvement over time. Most patients maintain their core sleep protocol long-term given that the underlying mechanisms are ongoing processes.

DSIP — 5mL (2mg/mL)

Direct delta wave sleep architecture promotion. No dependency or morning sedation.

Epithalon Injectable — 5mL (2mg/mL)

Pineal regulation and melatonin production restoration. Circadian entrainment.

Semax / Selank Nasal Spray

Selank GABAergic anxiolysis for cortisol-driven sleep disruption.

CJC-1295 / Ipamorelin — 5mL Injectable

Dual GH secretagogue. Strongest slow-wave sleep deepening in the catalog.

Sermorelin — 5mL Injectable

GHRH analog GH secretagogue. Conservative slow-wave sleep support.

Ibutamoren (MK-677) — 12.5mg, 30ct

Oral GH secretagogue. Published slow-wave sleep extension data.

Oxytocin Nasal Spray — 5mL (100IU/mL)

Parasympathetic shift and sleep onset support. Most affordable sleep compound.

Oxytocin Troche 50IU — 30ct

Sublingual oxytocin for sustained pre-sleep parasympathetic support.

Oxytocin Troche 120IU — 30ct

Higher-dose sublingual oxytocin for stronger pre-sleep effect.

Identify Your Primary Sleep Pattern

Is your core problem shallow, unrefreshing sleep despite adequate hours — suggesting architecture deficit? Difficulty falling asleep — suggesting onset and arousal? Gradually worsening sleep over years — suggesting age-related GH and circadian decline? Or sleep that deteriorates under stress — suggesting cortisol and HPA axis disruption?

Complete Your Async Provider Consultation

Answer a brief health intake at your own pace — describe your sleep pattern, how long it has been an issue, what you've tried, your stress level, and any relevant history. If you have wearable sleep data, include it. A licensed provider reviews your submission and issues your prescription when clinically appropriate.

Receive Your Order

Your prescription is filled by Optimal Balance Pharmacy and shipped via FedEx Standard Overnight. Syringes and alcohol swabs included with all injectable orders.

Build Toward the Complete Protocol

Most sleep protocols start with one or two acute-acting compounds — Oxytocin or DSIP for immediate architectural and onset effects — while slower foundation compounds (Epithalon, GH secretagogues) are added as the protocol matures.